Amplia Therapeutics Ltd
ASX:ATX
Cash Flow Statement
Cash Flow Statement
Amplia Therapeutics Ltd
| Mar-2016 | Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Stock-Based Compensation |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
(5)
N/A
|
(5)
-16%
|
(6)
-13%
|
(6)
+9%
|
(4)
+37%
|
(3)
+25%
|
(1)
+63%
|
(2)
-59%
|
(2)
-33%
|
(2)
+8%
|
(3)
-52%
|
(4)
-45%
|
(4)
-4%
|
(5)
-16%
|
(5)
-4%
|
(6)
-11%
|
(5)
+13%
|
(3)
+46%
|
(7)
-150%
|
(13)
-94%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-79%
|
(0)
+34%
|
(0)
+78%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-270%
|
(0)
-33%
|
(0)
-163%
|
(0)
+17%
|
(0)
+83%
|
(0)
+78%
|
(0)
-18%
|
(0)
+19%
|
(0)
-3 790%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
4
|
11
|
9
|
2
|
0
|
0
|
0
|
1
|
2
|
5
|
4
|
4
|
16
|
12
|
0
|
0
|
0
|
4
|
17
|
41
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
(0)
|
(0)
|
(0)
|
(2)
|
(0)
|
1
|
|
| Other |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(3)
|
(4)
|
|
| Cash from Financing Activities |
4
N/A
|
11
+163%
|
9
-17%
|
2
-75%
|
(0)
N/A
|
(0)
+22%
|
(0)
-21%
|
1
N/A
|
2
+80%
|
4
+128%
|
4
-18%
|
4
-1%
|
17
+372%
|
14
-21%
|
(0)
N/A
|
(0)
-90%
|
(1)
-383%
|
2
N/A
|
14
+751%
|
38
+165%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
(1)
N/A
|
5
N/A
|
3
-49%
|
(3)
N/A
|
(4)
-3%
|
(3)
+25%
|
(1)
+63%
|
(0)
+51%
|
(0)
+72%
|
3
N/A
|
1
-71%
|
(1)
N/A
|
13
N/A
|
9
-33%
|
(5)
N/A
|
(6)
-13%
|
(6)
+3%
|
(1)
+81%
|
7
N/A
|
25
+229%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(6)
-16%
|
(6)
-12%
|
(6)
+10%
|
(4)
+37%
|
(3)
+25%
|
(1)
+63%
|
(2)
-58%
|
(2)
-33%
|
(2)
+8%
|
(3)
-52%
|
(4)
-45%
|
(4)
-4%
|
(5)
-15%
|
(5)
-4%
|
(6)
-11%
|
(5)
+13%
|
(3)
+46%
|
(7)
-149%
|
(13)
-94%
|
|